中国输血依赖型地中海贫血异基因造血干细胞移植治疗指南(2026年)OA
Guideline for allogeneic hematopoietic stem cell transplantation in the treatment of transfusion-dependent thalassemia in China(2026)
该指南制订工作组对近10年异基因造血干细胞移植(allogeneic hematopoietic stem cell transplantation,allo-HSCT)治疗输血依赖型地中海贫血(transfusion-dependent thalassemia,TDT)相关文献进行全面检索、评价、遴选和整合,针对allo-HSCT治疗TDT相关的10个临床问题,形成26条推荐意见,旨在指导和规范我国allo-HSCT治疗TDT的临床诊疗实践.
A comprehensive retrieval,evaluation,selection,and integration of literature on allogeneic hematopoietic stem cell transplantation(allo-HSCT)for transfusion-dependent thalassemia(TDT)published over the past decade was conducted.For 10 clinical questions related to allo-HSCT in TDT,26 recommendations were developed.The guideline aims to guide and standardize clinical diagnosis and treatment practices of allo-HSCT for TDT in China.
中国妇幼保健协会地中海贫血防治专业委员会;中华医学会儿科学分会血液学组;全国地中海贫血防治协作网;《中国当代儿科杂志》编辑委员会;刘四喜;赖永榕;吴学东
深圳市儿童医院血液肿瘤科广西医科大学第一附属医院血液科南方医科大学南方医院儿科
输血依赖型地中海贫血异基因造血干细胞移植指南
Transfusion-dependent thalassemiaAllogeneic hematopoietic stem cell transplantationGuideline
《中国当代儿科杂志》 2026 (4)
389-401,13
评论